CHICAGO (MedPage Today) -- The recently approved HIV drug rilpivirine (Edurant) is easier to take for the first three months of therapy than the widely used efavirenz (Sustiva), a researcher said.
sustivaICAAC: New Drug Easier to Take than HIV Standard (CME/CE)MedPage Today Infectious Disease Thu, 09/22/2011 - 09:00
Stepped Dosing Lessens Neuropsychiatric Effects of Efavirenz (CM...MedPage Today Infectious Disease Mon, 07/06/2009 - 15:00
LITTLE FALLS, N.J. (MedPage Today) -- A stepwise dosing schedule eases the neuropsychiatric side effects of the HIV drug efavirenz (Sustiva), a randomized trial showed. |
